Related references
Note: Only part of the references are listed.Ab1 kinase regulation by BRAF/ERK and cooperation with Akt in melanoma
A. Jain et al.
ONCOGENE (2017)
Phenotypic tumour cell plasticity as a resistance mechanism and therapeutic target in melanoma
Alexander Roesch et al.
EUROPEAN JOURNAL OF CANCER (2016)
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells
Shira Ashkenazi et al.
ONCOTARGET (2016)
Cathepsin L targeting in cancer treatment
Dhivya R. Sudhan et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Sp1 transcription factor: A long-standing target in cancer chemotherapy
Carolina Vizcaino et al.
PHARMACOLOGY & THERAPEUTICS (2015)
The role of the transcription factor Ets1 in carcinoma
Juergen Dittmer
SEMINARS IN CANCER BIOLOGY (2015)
PAX3 and ETS1 synergistically activate MET expression in melanoma cells
J. D. Kubic et al.
ONCOGENE (2015)
Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response
Oakley C. Olson et al.
NATURE REVIEWS CANCER (2015)
The Emerging Role of ABL Kinases in Solid Tumors
Jun Wang et al.
TRENDS IN CANCER (2015)
RAB7 Controls Melanoma Progression by Exploiting a Lineage-Specific Wiring of the Endolysosomal Pathway
Direna Alonso-Curbelo et al.
CANCER CELL (2014)
The Tetraspanin CD81 Protein Increases Melanoma Cell Motility by Up-regulating Metalloproteinase MT1-MMP Expression through the Pro-oncogenic Akt-dependent Sp1 Activation Signaling Pathways
In-Kee Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells
Ju-Ying Tsai et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer
L. S. Fiore et al.
ONCOGENE (2014)
Cathepsin B: Multiple roles in cancer
Neha Aggarwal et al.
PROTEOMICS CLINICAL APPLICATIONS (2014)
The role of the cytoskeleton and molecular motors in endosomal dynamics
Elizabeth Granger et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Defying c-Abl signaling circuits through small allosteric compounds
Stefania Gonfloni
FRONTIERS IN GENETICS (2014)
A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma
Julie Caramel et al.
CANCER CELL (2013)
Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization
Donna M. Small et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
Jonathan T. Sims et al.
PLOS ONE (2013)
Role of ABL family kinases in cancer: from leukaemia to solid tumours
Emileigh K. Greuber et al.
NATURE REVIEWS CANCER (2013)
Cysteine cathepsins: From structure, function and regulation to new frontiers
Vito Turk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2012)
ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma
Barbara Spangler et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression
S. S. Ganguly et al.
ONCOGENE (2012)
Endosome maturation
Jatta Huotari et al.
EMBO JOURNAL (2011)
IL8 and Cathepsin B as Melanoma Serum Biomarkers
Hongtao Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Mithramycin A suppresses expression of the human melanoma-associated gene ABCB8
Iwona Sachrajda et al.
MOLECULAR GENETICS AND GENOMICS (2011)
Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway
A. A. Wani et al.
ONCOGENE (2011)
Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma
Gianfranco Mattia et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3
X. Li et al.
CELL DEATH AND DIFFERENTIATION (2010)
Conditional ablation of Ikkb inhibits melanoma tumor development in mice
Jinming Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma
Daniela Murtas et al.
ONCOLOGY LETTERS (2010)
The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis
Adam I. Riker et al.
BMC MEDICAL GENOMICS (2008)
SHP-2 is a novel target of Abl kinases during cell proliferation
Sayan Mitra et al.
JOURNAL OF CELL SCIENCE (2008)
Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival
D. Srinivasan et al.
ONCOGENE (2008)
Differences in the expression of cathepsin B in B16 melanoma metastatic variants depend on transcription factor Sp1
Yasmin Sitabkhan et al.
DNA AND CELL BIOLOGY (2007)
Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells
Divyamani Srinivasan et al.
CANCER RESEARCH (2006)
Novel genes associated with malignant melanoma but not benign melanocytic lesions
D Talantov et al.
CLINICAL CANCER RESEARCH (2005)
Bidirectional signaling links the Abelson kinases to the platelet-derived growth factor receptor
R Plattner et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Nuclear factor-κB mediates up-regulation of cathepsin B by doxorubicin in tumor cells
S Bien et al.
MOLECULAR PHARMACOLOGY (2004)
Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes
G Rumpler et al.
EXPERIMENTAL DERMATOLOGY (2003)
Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway
A Echarri et al.
CURRENT BIOLOGY (2001)
Transcription factors Ets1, NF-κB, and Sp1 are major determinants of the promoter activity of the human protein kinase CK2α gene
A Krehan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transcription of human cathepsin B is mediated by Sp1 and Ets family factors in glioma
SQ Yan et al.
DNA AND CELL BIOLOGY (2000)
Share Paper
